EMEA-002521-PIP01-18

Key facts

Active substance
Botulinum toxin type A
Therapeutic area
Dermatology
Decision number
P/0281/2019
PIP number
EMEA-002521-PIP01-18
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of skin wrinkling
Route(s) of administration
Intramuscular use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating